{
    "pubmed_id": 34150933,
    "study_identifier": "PMID34150933_study-01",
    "study_name": "Production of the Receptor-binding Domain of the Viral Spike Proteins from 2003 and 2019 SARS CoVs and the Four Common Human Coronaviruses for Serologic Assays and Inhibitor Screening",
    "publication_title": "Production of the Receptor-binding Domain of the Viral Spike Proteins from 2003 and 2019 SARS CoVs and the Four Common Human Coronaviruses for Serologic Assays and Inhibitor Screening",
    "study_objective": "To measure the expression and purification of properly folded RBD proteins from SARS and common-cold HCoVs in mammalian cells.",
    "study_description": "The recombinant receptor-binding domain (RBD) of the viral spike protein from SARS-CoV-1 and 2 are reliable antigens for detecting viral-specific antibodies in humans. We and others have shown that the levels of RBD-binding antibodies and SARS-CoV-2 neutralizing antibodies in patients are correlated. Here, we report the expression and purification of properly folded RBD proteins from SARS and common-cold HCoVs in mammalian cells. RBD proteins were produced with cleavable tags for affinity purification from the cell culture medium and to support multiple immunoassay platforms and drug discovery efforts. Graphic abstract: High-Yield Production of Viral Spike RBDs for Diagnostics and Drug Discovery",
    "primary_institution_name": "University of North Carolina at Chapel Hill",
    "study_personnel": [
        {
            "personnel_id": "PMID34150933_personnel-01",
            "honorific": "",
            "last_name": "Desilva",
            "first_name": "Aravinda",
            "suffixes": "",
            "organization": "University of North Carolina at Chapel Hill",
            "orchid_id": "",
            "email": "aravinda_desilva@med.unc.edu",
            "seronet_title_in_study": "SeroNet Investigator",
            "role_in_study": "Investigator",
            "site_name": "University of North Carolina at Chapel Hill"
        },
        {
            "personnel_id": "PMID34150933_personnel-02",
            "honorific": "",
            "last_name": "Prem",
            "first_name": "Lakshmanane",
            "suffixes": "",
            "organization": "University of North Carolina at Chapel Hill",
            "orchid_id": "",
            "email": "prem@med.unc.edu",
            "seronet_title_in_study": "SeroNet Investigator",
            "role_in_study": "Investigator",
            "site_name": "University of North Carolina at Chapel Hill"
        }
    ],
    "study_file": [
        {
            "study_file_name": "PMID34150933_SDS-PAGE-01.jpg",
            "study_file_description": "SDS-PAGE analysis of purified spike RBD proteins",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID34150933_v1.2.5.xlsx",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [],
    "research_focus": "Development",
    "study_type": "Method Development",
    "keyword": [
        "SARS-CoV-2",
        "SARS-CoV",
        "Coronavirus",
        "COVID-19",
        "Antigen",
        "Immunoassay",
        "Halo-tag",
        "Spike protein",
        "Antibody",
        "Inhibitor screening",
        "Drug discovery"
    ],
    "clinical_study_design": "",
    "in_silico_model_type": "Protein Structure Prediction",
    "protocol": {
        "protocol_id": "PMID34150933_protocol-01",
        "protocol_file_name": "PMID34150933_protocol-01.txt",
        "protocol_name": "PMID34150933_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19"
    ],
    "sars_cov_2_vaccine_type": [
        "N/A"
    ],
    "clinical_outcome_measure": "",
    "enrollment_start_date": "",
    "enrollment_end_date": "",
    "number_of_study_subjects": "",
    "age_unit": "Years",
    "minimum_age": "",
    "maximum_age": "",
    "study_human_cohort": [],
    "study_model_cohort": [
        {
            "arm_id": "PMID34150933_organism_subject-01",
            "arm_name": "Mammalian cells",
            "study_population_description": "Expression and purification of properly folded RBD proteins from SARS and common-cold HCoVs in mammalian cells",
            "arm_type": "Experimental Arm",
            "genus_and_species": [
                "Homo sapiens"
            ],
            "biosample_type": [
                "Cell Line"
            ],
            "strain_characteristics": [],
            "sex_at_birth": [],
            "age_event": "",
            "subject_phenotype": "",
            "study_location": [
                "US: North Carolina"
            ],
            "sars_cov_2_history": [],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [],
            "post_covid_19_symptons": [],
            "covid_19_complications": []
        }
    ],
    "planned_visit": [
        {
            "visit_id": "PMID34150933_visit-01",
            "visit_name": "Model",
            "visit_order_number": 1,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [],
    "geriatric_subjects": "Not Specified",
    "pediatric_subjects": "Not Specified",
    "pregnant_subjects": "Not Specified",
    "sars_cov_2_antibodies_measured": "Not Specified",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID34150933_inexcl-01",
            "inclusion_criterion": "Not specified",
            "inclusion_criterion_category": "inclusion"
        }
    ],
    "suggestions": [
        "2003",
        "2019",
        "abstract",
        "affinity",
        "antibodies",
        "antibody",
        "antigen",
        "antigens",
        "assays",
        "carolina",
        "cell",
        "cells",
        "chapel",
        "cleavable",
        "common",
        "common-cold",
        "coronavirus",
        "coronaviruses",
        "correlated",
        "covid-19",
        "covs",
        "culture",
        "detecting",
        "development",
        "diagnostics",
        "discovery",
        "domain",
        "drug",
        "drug discovery",
        "efforts",
        "expression",
        "folded",
        "four",
        "graphic",
        "halo-tag",
        "hcovs",
        "high-yield",
        "hill",
        "human",
        "humans",
        "immunoassay",
        "inhibitor",
        "inhibitor screening",
        "levels",
        "mammalian",
        "measure",
        "medium",
        "method",
        "multiple",
        "n/a",
        "neutralizing",
        "north",
        "others",
        "patients",
        "platforms",
        "produced",
        "production",
        "properly",
        "protein",
        "proteins",
        "purification",
        "rbd",
        "rbd-binding",
        "rbds",
        "receptor-binding",
        "recombinant",
        "reliable",
        "report",
        "sars",
        "sars-cov",
        "sars-cov-1",
        "sars-cov-2",
        "screening",
        "serologic",
        "shown",
        "specified",
        "spike",
        "spike protein",
        "support",
        "tags",
        "university",
        "viral",
        "viral-specific"
    ]
}